LSS缺失通过下调NPC1L1与激活CD36/TLR4/JNK通路改善MASLDOA
LSS deficiency ameliorates MASLD by downregulating NPC1L1 and activating the CD36/TLR4/JNK pathway
目的 探究羊毛甾醇合酶(LSS)肠道缺失是否通过调控肠道胆固醇吸收与免疫应答影响代谢功能障碍相关脂肪性肝病(MASLD)进展.方法 利用CRISPR/Cas9技术构建LSS杂合敲除(LSS+/-)小鼠及野生型(WT)对照,分别饲喂高脂饲料(HFD)或普通饲料(CHOW).通过基因型鉴定验证模型;肝脏HE和油红O染色评估脂肪变性;免疫组化检测肠道NPC1L1和CD36蛋白定位与表达;Western blot分析肠道JNK磷酸化和TLR4蛋白水平;实时荧光定量聚合酶链式反应(qPCR)检测TLR4和IL-6的mRNA表达.结果 LSS+/-小鼠经基因型鉴定及小肠LSS蛋白检测结果表明LSS敲低小鼠构建成功.肝脏HE及油红O染色显示,与CHOW喂养的WT小鼠相比,HFD喂养的WT小鼠肝脏脂质空泡增多;而与HFD喂养的WT小鼠相比,HFD喂养的LSS+/-小鼠肝脏脂质沉积明显减轻,血清丙氨酸氨基转移酶(ALT)水平亦降低(P<0.05).免疫组化检测显示,与WT小鼠相比,LSS+/-小鼠小肠绒毛中胆固醇吸收蛋白NPC1L1的表达在CHOW及HFD条件下均下调(PHFD<0.001);而脂肪酸转运蛋白CD36在LSS+/-小鼠小肠中表达上调(PCHOW<0.05,PHFD<0.01).Western blot结果显示,与WT小鼠相比,LSS+/-小鼠小肠中TLR4蛋白表达在CHOW及HFD条件下均升高(均P<0.05);在CHOW条件下,LSS+/-小鼠JNK磷酸化水平升高(均P<0.05);在HFD条件下,LSS+/-小鼠总JNK蛋白表达增加,但磷酸化水平无显著变化.qPCR检测显示,与WT小鼠相比,LSS+/-小鼠小肠中TLR4 mRNA(PCHOW<0.01,PHFD<0.000 1)及IL-6 mRNA(PCHOW<0.001,PHFD<0.01)均显著上调.结论 LSS缺失通过诱导肠道胆固醇吸收限制、脂肪酸利用促进及免疫通路激活的协同重编程,抵抗肝脏脂质沉积,提示肠道LSS是MASLD的潜在治疗靶点.
Objective To investigate whether intestinal deficiency of lanosterol synthase(LSS),a key enzyme in cholesterol synthesis,influences the progression of metabolic dysfunction-associated steatotic liver disease(MASLD)by regulating intestinal cholesterol absorption and immune response.Methods LSS heterozygous knockout(LSS+/-)mice and wild-type(WT)controls were generated using CRISPR/Cas9 technology and fed either a high-fat diet(HFD)or regular chow(CHOW).The model was validated by genotyping.Hepatic steatosis was as-sessed by HE and oil red O staining.Immunohistochemistry was used to detect the localization and expression of NPC1L1 and CD36 proteins in the intestine.Western blot analysis was performed to measure JNK phosphorylation and TLR4 protein levels in intestinal tissues.Real-time quantitative polymerase chain reaction(qPCR)was em-ployed to examine the mRNA expression of TLR4 and IL-6.Results LSS+/-mice were successfully validated by ge-notyping and reduced intestinal LSS protein expression.HE and oil red O staining of liver sections showed that,compared with WT mice fed a CHOW diet,WT mice fed a HFD exhibited a marked increase in hepatic lipid vacu-oles.In contrast,compared with HFD-fed WT mice,HFD-fed LSS+/-mice displayed significantly attenuated he-patic lipid deposition and reduced serum ALT levels(P<0.05).Immunohistochemical analysis revealed that,com-pared with WT mice,the expression of the cholesterol absorption protein NPC1L1 in the intestinal villi of LSS+/-mice was downregulated under both CHOW and HFD conditions(PHFD<0.001).Conversely,the expression of the fatty acid transporter CD36 was upregulated in the intestines of LSS+/-mice(PCHOW<0.05,PHFD<0.01).Western blot analysis demonstrated that,compared with WT mice,TLR4 protein expression in the intestines of LSS+/-mice significantly increased under both CHOW and HFD conditions(both P<0.05).JNK phosphorylation level was sig-nificantly elevated in LSS+/-mice under CHOW condition(both P<0.05).Under HFD condition,total JNK protein expression increased,but its phosphorylation level showed no significant change.qPCR analysis showed that,com-pared with WT mice,the mRNA levels of TLR4(PCHOW<0.01,PHFD<0.000 1)and IL-6(PCHOW<0.001,PHFD<0.01)were significantly upregulated in the intestines of LSS+/-mice.Conclusion LSS deficiency counteracts he-patic lipid deposition by orchestrating a synergistic reprogramming involving restricted intestinal cholesterol absorp-tion,enhanced fatty acid utilization,and activation of immune pathways,suggesting intestinal LSS as a potential therapeutic target of MASLD.
王子涵;白红枚;何清雅;周文静;钟健;江小丽;张素梅;张胜权
安徽医科大学基础医学院生物化学与分子生物学教研室,合肥 230032安徽医科大学基础医学院生物化学与分子生物学教研室,合肥 230032安徽医科大学基础医学院生物化学与分子生物学教研室,合肥 230032安徽医科大学基础医学院生物化学与分子生物学教研室,合肥 230032安徽医科大学基础医学院生物化学与分子生物学教研室,合肥 230032安徽医科大学基础医学院生物化学与分子生物学教研室,合肥 230032安徽医科大学基础医学院生物化学与分子生物学教研室,合肥 230032安徽医科大学基础医学院生物化学与分子生物学教研室,合肥 230032
医药卫生
代谢障碍相关脂肪肝病LSS肠-肝轴胆固醇吸收肠道免疫脂肪肝模型
metabolic dysfunction-associated steatotic liver diseaselanosterol synthasegut-liver axischolesterol absorptiongut immunityfatty liver model
《安徽医科大学学报》 2026 (5)
812-818,7
安徽省自然科学基金项目(编号:2108085MH266) Natural Science Foundation of Anhui Province(No.2108085MH266)
评论